Related Experiment Video

Updated: May 13, 2026

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
13:20

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro

Published on: July 17, 2018

A unifying mechanism for cancer cell death through ion channel activation by HAMLET

Petter Storm1, Thomas Kjaer Klausen, Maria Trulsson

  • 1Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden.

Plos One
|March 19, 2013
PubMed

Insights

The protein-lipid complex HAMLET rapidly triggers ion channel activity, causing cancer cell death. This mechanism, involving specific ion fluxes and p38 MAPK activation, offers a dual therapeutic approach for cancer treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Biophysics

Background:

  • Tissue homeostasis relies on ion channels and fluxes.
  • Tumor-specific ion fluxes during oncogenic transformation are not well-defined.
  • The tumoricidal protein-lipid complex HAMLET can probe these processes.

Purpose of the Study:

  • To identify ion fluxes critical for tumor cell death induced by HAMLET.
  • To elucidate the mechanism of HAMLET-induced cell death.
  • To explore HAMLET's therapeutic potential.

Main Methods:

  • Application of HAMLET to carcinoma cells.
  • Measurement of ion currents and cellular ion concentrations (Na+, K+).
  • Inhibition studies using amiloride and BaCl2.
  • Global transcriptional analysis and phosphorylation arrays.
  • MAP kinase (MAPK) pathway analysis.

Main Results:

  • HAMLET activates a non-selective cation current (2.74±0.88 nA within 1.43±0.13 min).
  • Inhibiting ion fluxes prevented HAMLET-induced changes in cell morphology, uptake, transcription, and MAPK activation.
  • A significant ion flux-dependent p38 MAPK response was identified; its inhibition delayed cell death.
  • Healthy cells showed resistance to HAMLET, activating innate immunity instead of p38 MAPK.

Conclusions:

  • HAMLET initiates tumor cell death through rapid, non-selective cation flux activation.
  • The p38 MAPK pathway is a key mediator of HAMLET-induced cancer cell death.
  • HAMLET demonstrates a dual therapeutic strategy: direct tumor cell killing and innate immune stimulation in surrounding healthy tissue.

More Related Videos

Screening Ion Channels in Cancer Cells06:19

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation06:12

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation

Published on: May 3, 2024

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.